Belpointe Asset Management LLC Purchases Shares of 1,716 Encompass Health Corporation $EHC

Belpointe Asset Management LLC purchased a new stake in Encompass Health Corporation (NYSE:EHC) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,716 shares of the company’s stock, valued at approximately $210,000.

Other large investors also recently bought and sold shares of the company. WPG Advisers LLC acquired a new position in Encompass Health in the first quarter valued at approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Encompass Health by 749.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after acquiring an additional 367 shares during the period. Arlington Trust Co LLC lifted its holdings in Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock valued at $68,000 after acquiring an additional 125 shares during the period. Park Place Capital Corp acquired a new position in Encompass Health in the second quarter valued at approximately $72,000. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after acquiring an additional 115 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Down 0.9%

Shares of EHC opened at $122.02 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.86. The stock has a market capitalization of $12.29 billion, a price-to-earnings ratio of 23.88, a PEG ratio of 2.14 and a beta of 0.93. The stock has a 50 day moving average price of $122.73 and a 200 day moving average price of $116.50.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The firm had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities research analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.19 per share. The ex-dividend date is Wednesday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. Encompass Health’s dividend payout ratio (DPR) is presently 14.87%.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday. Bank of America boosted their price objective on Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. Truist Financial boosted their price objective on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research report on Thursday, August 14th. UBS Group boosted their price objective on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. Finally, KeyCorp boosted their price objective on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Tuesday, September 16th. One equities research analyst has rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $139.86.

Insider Activity at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.00% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.